Butterfly Network is trading 4.24% down now at $8.58, amid broader healthcare weakness; the precise cause of the decline is unconfirmed. - Healthcare ETF XLV is down 1.33%, while higher Treasury yields are pressuring growth-oriented medical-device stocks. - On October 1, the company announced Mendaera’s Focalist system is commercially available with Butterfly’s ultrasound technology, a positive partnership update; no company-specific bad news has surfaced. - A contemporaneous market summary described the move as consolidation after a recent run-up.